Screening for vascular disease saves one life for every 169 patients assessed (VIVA)

(European Society of Cardiology) A novel screening program for vascular disease saves one life for every 169 men assessed, according to late-breaking results from the VIVA trial presented today in a Hot Line LBCT Session at ESC Congress and published in the Lancet. The combined screening for abdominal aortic aneurysm, peripheral artery disease, and hypertension gained more living years for lower costs than European cancer screening programs.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news